Skip to content
sellWeak cluster of 210b5-1 plan

BENKOWITZ MICHAEL sold $3.6M of UTHR

PRESIDENT AND COO at UNITED THERAPEUTICS Corp. 10,000 shares at an average of $355.15, traded Jan 6, 2025, filed Jan 7, 2025.

Warning score
38
Value
$3.6M
10,000 shares
Holdings after
0
-133% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001562180-25-000239, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 6, 2025MOption exercise
Common Stockindirect: By Trust10b5-1
+7,500$111.00$833k7,500Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-1,022$353.60$361k6,478Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-3,620$354.59$1.3M2,858Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-1,458$355.30$518k1,400Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-419$356.61$149k981Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-681$357.54$243k300Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-300$358.32$107k0Jan 7, 2025
Jan 6, 2025MOption exercise
Common Stockindirect: By Trust10b5-1
+2,500$111.00$278k2,500Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-700$353.91$248k1,800Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-1,180$355.04$419k620Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-200$355.79$71k420Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-220$357.26$79k200Jan 7, 2025
Jan 6, 2025SOpen-market sale
Common Stockindirect: By Trust10b5-1
-200$358.30$72k0Jan 7, 2025
Jan 6, 2025MOption exercise
Stock Optionsderivativeindirect: By Trust10b5-1
-2,500$0.00$022,000Jan 7, 2025
Jan 6, 2025MOption exercise
Stock Optionsderivativeindirect: By Trust10b5-1
-7,500$0.00$059,679Jan 7, 2025

Related signals

Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
25Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$640k2,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.0M9,679
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.6M10,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.7M10,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.5M10,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.5M10,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.7M10,000
30Weaksell10b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.6M10,000
38Weaksell 210b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.6M10,000
45Moderatesell 310b5-1UTHR
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
PRESIDENT AND COO
$3.6M10,000

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

BENKOWITZ MICHAEL sold $3.6M of UTHR | InsiderTell